ALTERNATING THYROID STATUS BETWEEN THYROTOXICOSIS AND HYPOTHYROIDISM IN A PATIENT WITH VARYING ANTITHYROID ANTIBODIES

Autoimmune pathologies are a growing aspect of medicine. Knowledge about atypical cases is essential. This report will describe a case of unusual, alternating fluctuations in thyroid function. We report a case of thyrotoxicosis alternating with hypothyroidism in a 44-year-old, African-American woman...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AACE clinical case reports 2019-03, Vol.5 (2), p.e112-e118
Hauptverfasser: Solaimanzadeh, Isaac, Hossain, Muhammad Rajib, Shiferaw-Deribe, Zewge, Sandhu, Hargeet
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Autoimmune pathologies are a growing aspect of medicine. Knowledge about atypical cases is essential. This report will describe a case of unusual, alternating fluctuations in thyroid function. We report a case of thyrotoxicosis alternating with hypothyroidism in a 44-year-old, African-American woman and detail the clinical course and management. The patient presented in a mildly thyrotoxic state with features of thyroiditis that resolved soon thereafter. Subsequently, the course shifted toward a hypothyroid state with a thyroid-stimulating hormone (TSH) level of 24.53 μIU/ml (normal range is 0.45 to 4.5 μIU/ml; measured September 5, 2013) and free thyroxine (FT4) of 0.35 ng/dL (normal range is 0.5 to 1.40 ng/dL; measured September 5, 2013). It ensued with alternating hypothyroid and hyperthyroid trajectories for several cycles. Clinical management was adjusted to negotiate each progression. During certain intervals, levothyroxine was increased. At other visits, it was decreased. Periods without medication were observed as well. Furthermore, methimazole and metoprolol were utilized when required. Reversal of the condition occurred repeatedly. The entire course is tracked with over 30 instances of thyroid function measures that included hypothyroid, euthyroid (TSH at 1.54 μIU/mL, FT4 at 1.16 ng/dL) and thyrotoxic states (TSH at
ISSN:2376-0605
2376-0605
DOI:10.4158/ACCR-2018-0167